CD200 and neoplasm: To assess the impact of CD200-CD200R signaling on the diversity of the immune repertoire of tumor-infiltrating T cells, we prepared genomic DNA from tumors (n = 4/group) and performed TCR-seq analysis (Adaptive Technology, Seattle, Washington).